PD153035 hydrochloride

CAS No. 183322-45-4

PD153035 hydrochloride ( AG-1517 )

Catalog No. M12831 CAS No. 183322-45-4

PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 56 In Stock
25MG 113 In Stock
50MG 221 In Stock
100MG 375 In Stock
500MG 853 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD153035 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.
  • Description
    PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.
  • Synonyms
    AG-1517
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    183322-45-4
  • Formula Weight
    396.67
  • Molecular Formula
    C16H15BrClN3O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 0.5 mg/mL (1.26 mM)
  • SMILES
    COc(c1)c(OC)cc2c1ncnc2Nc3cc(Br)ccc3.Cl
  • Chemical Name
    N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
  • HKI-357

    HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 (IC50s: 34 nM and 33 nM). HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.

  • Lapatinib ditosylate

    A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.

  • Beta-Hydroxyisovaler...

    Beta-Hydroxyisovalerylshikonin is an inhibitor of protein-tyrosine kinases such as v-Src and EGFR, and has been shown to induce apoptosis in several human tumor cell lines. Beta-Hydroxyisovalerylshikonin significantly decreased viability of HCT116 cells (IC50 values = 30.9 μg/mL).